In-vitro susceptibilities of species of the Bacteroides fragilis group to newer β-lactam agents

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 1, 1999, Pages 133-136

  Betriu, Carmen ^a   Sánchez, Ana ^a   Gómez, María ^a   Palau, M Luisa ^a   Picazo, Juan J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFOXITIN; CEFTIZOXIME; CHLORAMPHENICOL; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; MEZLOCILLIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIMENTIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEROIDES FRAGILIS; CONTROLLED STUDY; NONHUMAN; STRAIN DIFFERENCE;

AMOXICILLIN; AMPICILLIN; ANTI-BACTERIAL AGENTS; BACTEROIDES FRAGILIS; BETA-LACTAMASES; CEFOXITIN; CEFTIZOXIME; CHLORAMPHENICOL; CLAVULANIC ACID; CLINDAMYCIN; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; IMIPENEM; METRONIDAZOLE; MEZLOCILLIN; MICROBIAL SENSITIVITY TESTS; PENICILLANIC ACID; PENICILLINS; PIPERACILLIN; SPECIES SPECIFICITY; SULBACTAM; THIENAMYCINS; TICARCILLIN;

EID: 0344428140     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.1.133     Document Type: Article

References (10)

1. Pélaez, M. T., Cercenado, E., Rodriguez-Creixems, M. & Bouza, E. (1991). Resistance of anaerobic bacteria to antimicrobial agents. Reviews of Infectious Diseases 13, 183.
2. Betriu, C., Cabronero, C., Gómez, M. & Picazo, J. J. (1992). Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989. European Journal of Clinical Microbiology and Infectious Diseases 11, 352-6.
3. Bandoh, K., Ueno, K., Watanabe, K. & Kato, N. (1993). Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study. Clinical Infectious Diseases 16, Suppl. 4, S382-6.
4. Aldridge, K. E., Gelfand, M., Reller, L. B., Ayers, L. W., Pierson, C. L., Schoenknecth, F. et al. (1994). A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States. Diagnostic Microbiology and Infectious Diseases 18, 235-41.
5. Dubreuil, L. (1996). Bacteroides fragilis: état de la sensibilité aux antibiotiques, évolution des résistances. Médicine et Malaladies Infectieuses 26, 196-207.
6. Baquero, F. & Reig, M. (1992). Resistance of anaerobic bacteria to antimicrobial agents in Spain. European Journal of Clinical Microbiology and Infectious Diseases 11, 1016-20.
7. Phillips, I., King, A., Nord, C. E. & Hoffstedt, B. (1992). Antibiotic sensitivity of the Bacteroides fragilis group in Europe. European Journal of Clinical Microbiology and Infectious Diseases 11, 292-304.
8. National Committee for Clinical Laboratory Standards. (1993). Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria-Third Edition: Approved Standard. M11-A3. NCCLS, Villanova, PA.
9. Mastrantonio, P., Spigaglia, P. & Sebastianelli, A. (1994). Susceptibility patterns and characterization of beta-lactamases in clinical isolates of Bacteroides fragilis. European Journal of Clinical Microbiology and Infectious Diseases 13, 475-80.
10. Payne, D. J., Betriu, C., Kushi, T., Hoyle, C., Reading, C. & Knowles, D. (1995). Imipenem hydrolysing β-lactamases from 6 strains of B. fragilis. In Program and Abstracts of the 95th General Meeting of the American Society for Microbiology, Washington, DC, 1995. Abstract A75, p. 156. American Society for Microbiology, Washington, DC.